AHA/ASA Journals2d
Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry
BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...
MedPage Today on MSN4d
Sotatercept Helps the Sickest Patients With Pulmonary Arterial Hypertension
Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients ...
American Association of Individual Investors5d
Why Tenaya Therapeutics, Inc.’s (TNYA) Stock Is Down 11.06%
Tenaya Therapeutics, Inc.’s TNYA share price has dipped by 11.06%, which has investors questioning if this is right time to buy.
American Association of Individual Investors5d
Why Verve Therapeutics, Inc.’s (VERV) Stock Is Down 11.69%
Verve Therapeutics, Inc.’s VERV share price has dipped by 11.69%, which has investors questioning if this is right time to buy.